After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Neurocrine Biosciences, Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Neurocrine Biosciences, Inc is $13.93B. A total of 0.77 million shares were traded on the day, compared to an average of 876.12K shares.
In the most recent transaction, GORMAN KEVIN CHARLES sold 106,322 shares of NBIX for 126.41 per share on Aug 07 ’25. After the transaction, the Director now owns 514,596 company shares. In a previous transaction on Aug 07 ’25, KEVIN CHARLES GORMAN bought 106,322 shares at 128.43 per share.
Among the insiders who sold shares, Delaet Ingrid disposed of 457 shares on Jul 10 ’25 at a per-share price of $135.00. This resulted in the Chief Regulatory Officer holding 4,730 shares of NBIX after the transaction. In another insider transaction, Onyia Jude sold 59,819 shares at $130.46 per share on Jul 09 ’25. Company shares held by the Chief Scientific Officer now total 18,289.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NBIX has a high of $154.61 and a low of $84.23.
As of this writing, NBIX has an earnings estimate of $2.09 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $2.54 per share and a lower estimate of $1.85. The company reported an EPS of $1.81 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $27.22, while its Total Shareholder’s Equity was $1.37B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.63.
